Systemic infusion of angiotensin II into normal rats activates nuclear factor-κB and AP-1 in the kidney role of A T1 and AT2 receptors

American Journal of Pathology

Volumn 158, Issue 5, 2001, Pages 1743-1756

  Ruiz Ortega, Marta ^a,c   Lorenzo, Óscar ^a   Rupérez, Mónica ^a   Blanco, Julia ^b   Egido, Jesus ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; INFLAMMATION; INFLAMMATORY CELL; KIDNEY INJURY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

EID: 0035022368     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64130-2     Document Type: Article

References (70)

1. Vasoactive hormones and renal sclerosis
2. Angiotensin II as a renal growth factor
3. Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 gene expression
4. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
5. Renal injury from angiotensin II-mediated hypertension
6. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats
7. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat
8. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
9. Angiontensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the Angiotensin type 2 receptor
10. Angiotensin peptides and inducible transcription factors
11. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
12. Angiotensin II induction of fibronectin biosynthesis in cultured human mesangial cells: Association with CREB transcription factor activation
13. Angiotensin converting enzyme inhibition prevents arterial NF-κB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
14. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases
15. AP-1 function and regulation
16. Rapid communication: Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction
17. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats
18. Angiotensin II receptors and angiotensin II receptor antagonist
19. Physiological and pharmacological implications of AT1 versus AT2 receptors
20. Counterpoint: Molecular analysis of the angiotensin II receptor
21. Pathophysiological role of Angiotensin II type 2 receptor in cardiovascular and renal diseases
22. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats
23. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism
24. 2) receptor protein in rat kidney
25. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor
26. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system
27. Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats
28. 2 receptor subtypes in vascular trophic changes in response to stimulation with angiotensin II
29. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure
30. In situ nonradioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry
31. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis
32. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts
33. 2-dependent signaling in rabbit proximal tubular epithelial cells
34. Growth dependent induction of angiotensin II type 2 receptor in rat mesangial cells
35. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes
36. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
37. Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: Molecular mechanisms of anti-nephritic action
38. Expression of nuclear factor kappa B (NF-κ B) assessed by Southwestern histochemistry (SWH) is associated with renal injury in IgA nephropathy (IgAN)
39. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats
40. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress
41. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice
42. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
43. Activation of human peripheral monocytes by angiotensin II
44. Angiotensin III increases monocytic chemotactic protein-1 and activates nuclear transcription factor κB and activator protein-1 in cultured mesangial and mononuclear cells
45. Adhesion of U-937 monocytes in- duces cytotoxic damage and subsequent proliferation of cultured human mesangial cells
46. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
47. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype
48. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor
49. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
50. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
51. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis
52. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function
53. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor
54. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction
55. AT1-receptor antagonist abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis
56. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis
57. Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
58. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring
59. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
60. Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells
61. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors
62. 2 receptors in cultured vascular smooth muscle cells. Molecular mechanisms
63. Angiotensin II alters aortic fibronectin independently of hypertension
64. Involvement of angiotensin II in cardiovascular and renal injury: Effects of an AT1-receptor antagonist on gene expression and the cellular phenotype
65. Increased brain transcription factor expression by angiotensin in genetic hypertension
66. Oral administration of losartan influences aminopeptidase activity in the frontal cortex
67. Proteinuric potentials of angiotensin II, [des-Asp1]-angiotensin II, and [des-Asp1, des-Arg2]-angiotensin II in rats
68. Angiotensin III upregulates genes involved in kidney damage in cultured mesangial cells and renal interstitial fibroblast
69. Glomerular mRNA expression of angiotensinase A after renal ablation
70. Angiotensinase A gene expression and activity in isolated glomeruli of diabetic rats